» Articles » PMID: 19532085

Recurrent Bacterial Vaginosis

Overview
Date 2009 Jun 18
PMID 19532085
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Bacterial vaginosis is a common condition that recurs frequently, adversely affecting women's lives, and is associated with complications including increased risk of sexually transmitted infections, HIV, and adverse pregnancy outcome.

Recent Findings: New molecular techniques have increased our understanding of the numerous bacteria associated with bacterial vaginosis, and a biofilm containing mostly Gardnerella and Atopobium vaginae, which can persist after treatment has been described. Suppressive treatment with metronidazole gel can suppress recurrence. Physiological approaches such as acidification and probiotics have been investigated with variable results.

Summary: Advances in our understanding of the pathogenesis of bacterial vaginosis allow the opportunity to improve treatments to prevent recurrence, which may require a combination of modalities. We must find ways to help affected women and reduce the complications associated with bacterial vaginosis.

Citing Articles

Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis.

Ma S, Wang W, Su Y, Sun W, Ma L Open Med (Wars). 2023; 18(1):20230644.

PMID: 37724125 PMC: 10505304. DOI: 10.1515/med-2023-0644.


Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial.

Ross J, Brittain C, Anstey Watkins J, Kai J, David M, Ozolins M BMC Womens Health. 2023; 23(1):241.

PMID: 37161454 PMC: 10169495. DOI: 10.1186/s12905-023-02303-5.


The female reproductive tract microbiotas, inflammation, and gynecological conditions.

Gholiof M, Adamson-De Luca E, Wessels J Front Reprod Health. 2022; 4:963752.

PMID: 36303679 PMC: 9580710. DOI: 10.3389/frph.2022.963752.


Association of key species of vaginal bacteria of recurrent bacterial vaginosis patients before and after oral metronidazole therapy with short- and long-term clinical outcomes.

Mollin A, Katta M, Sobel J, Akins R PLoS One. 2022; 17(7):e0272012.

PMID: 35901180 PMC: 9333308. DOI: 10.1371/journal.pone.0272012.


The Female Vaginal Microbiome in Health and Bacterial Vaginosis.

Chen X, Lu Y, Chen T, Li R Front Cell Infect Microbiol. 2021; 11:631972.

PMID: 33898328 PMC: 8058480. DOI: 10.3389/fcimb.2021.631972.